EUVIMEDEUVIMED entdecken
Open Access

Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification

Shiyu Wang, Yinshuang Lai, Huijing Huang, Jing Yuan, Shanxin Li, Min Hui, Peipei Wang, Bingbing Chen, Zhiguo Liu, Jianchang Qian, Qianwen Zhang

Acta Biochimica et Biophysica Sinica · 2025

DOI: 10.3724/abbs.2025076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Shiyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Resistance, Neoplasm, Curcumin. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsDrug Resistance, NeoplasmCurcuminProtein Kinase InhibitorsAntineoplastic AgentsDioxolanesHumansErbB ReceptorsAnimalsCell ProliferationApoptosisNetwork PharmacologyCell Line, TumorMolecular Docking SimulationSignal TransductionMiceXenograft Model Antitumor AssaysMice, NudeMice, Inbred BALB CPiperidones

Stichwörter der Autor:innen

EGFR-TKIPI3K/AKT pathwaycurcuminnon-small cell lung cancerpiperlongumineresistance

Substanzen

ErbB ReceptorsCurcuminProtein Kinase InhibitorsEGFR protein, humanAntineoplastic AgentspiperlongumineDioxolanesPiperidones

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  • Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  • Yueqing People's Hospital, Wenzhou 325035, China.
  • Department of Pharmacy, Changhai Hospital, Naval Medical University, Shanghai 200433, China.

Zitieren

APA

Wang, S., Lai, Y., Huang, H., Yuan, J., Li, S., Hui, M., Wang, P., Chen, B., Liu, Z., Qian, J., & Zhang, Q. (2025). Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025076

Vancouver

Wang S, Lai Y, Huang H, Yuan J, Li S, Hui M, et al. Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025076

BibTeX
@article{Wang2025,
  author = {Wang, Shiyu and Lai, Yinshuang and Huang, Huijing and Yuan, Jing and Li, Shanxin and Hui, Min and Wang, Peipei and Chen, Bingbing and Liu, Zhiguo and Qian, Jianchang and Zhang, Qianwen},
  title = {Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2025},
  doi = {10.3724/abbs.2025076}
}
Kostenlos starten →